Skip to main content
Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
2.920
-0.120 (-3.95%)
At close: Nov 20, 2024, 4:00 PM
2.870
-0.050 (-1.71%)
Pre-market: Nov 21, 2024, 5:50 AM EST

SONN Revenue

Sonnet BioTherapeutics Holdings had revenue of $55.88K in the twelve months ending June 30, 2024, down -67.76% year-over-year. In the fiscal year ending September 30, 2023, Sonnet BioTherapeutics Holdings had annual revenue of $147.81K, down -57.76%.

Revenue (ttm)
$55.88K
Revenue Growth
-67.76%
P/S Ratio
151.13
Revenue / Employee
$4,657
Employees
12
Market Cap
1.90M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023147.81K-202.14K-57.76%
Sep 30, 2022349.94K-133.68K-27.64%
Sep 30, 2021483.63K--
Sep 30, 2020---
Sep 30, 2019---
Sep 30, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

SONN News

More News